Dr. Amir R. Dehdashti

"Amir Dehdashti, MD, FACS, is a renowned neurosurgeon, and one of the few dual-trained cerebrovascular and skull base surgeons in America. He serves as the director of cerebrovascular neurosurgery research at North Shore University Hospital, and Professor of Neurosurgery at the Zucker School of Medicine at Hofstra/Northwell.Dr. Dehdashti's areas of expertise include cerebrovascular surgery for brain aneurysms and arteriovenous malformations, brainstem cavernous malformations, carotid artery disease, and bypass surgery for moyamoya disease and brain aneurysms. He specializes in skull base surgery for acoustic neuromas and meningiomas, minimally invasive endoscopic skull base surgery for pituitary and other skull base tumors, cranial nerve surgery for trigeminal neuralgia and hemifacial spasm, and craniovertebral junction surgery including Chiari. He has developed minimally invasive approaches to many complex cerebrovascular and cranial base diseases, and is one of a few neurosurgeons in the country with internationally recognized expertise in bypass surgery. With 14 years in practice as a board-certified neurosurgeon, Dr. Dehdashti understands the intricacies and delicate nature of brain surgery, and approaches each unique case with meticulous attention to detail. He is dedicated to providing the latest, most effective surgical options that offer the best possible outcomes, which is why patients both nationally and internationally are often referred to him. A global leader in neurosurgical research, Dr. Dehdashti has been published in more than 170 medical papers, including the textbook ""Surgery of Craniovertebral Junction.

Dr. Dehdashti is rated as a Distinguished provider by MediFind in the treatment of Prolactinoma. His top areas of expertise are Moyamoya Disease, Pituitary Tumor, Cerebral Arteriovenous Malformation, Cerebral Artery Bypass Surgery, and Extracranial-Intracranial Bypass Surgery.

His clinical research consists of co-authoring 133 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Prolactinoma.